NYSE:HUMHealthcare
Humana (NYSE:HUM) Revises 2025 Earnings Guidance Despite Strong Q1 Performance
Humana (NYSE:HUM) recently reported significant growth in its Q1 earnings, with revenue and net income seeing substantial increases compared to the previous year. Nonetheless, the company revised its full-year earnings guidance downward, reflecting a more cautious outlook. Despite these developments, Humana's stock performance remained flat over the past week. During the same period, broader markets saw gains, bolstered by strong earnings from major tech companies. Humana's individual...